Open Access in the developing World

Open Access and the developing World 



The free exchange of scientific and medical information can play an important role in international development.

BioMed Central provides free, immediate online access to the full text of all research articles published within its portfolio of 276 peer-reviewed journals, and through its open access waiver fund, enables scientific authors in low-income countries to overcome the financial barriers to publishing in open access journals.

Open access provides a way for researchers from low-income countries to participate more fully in the international research community, and so BioMed Central has created a set of initiatives designed to increase the visibility and output of scientific research from these countries.

http://www.biomedcentral.com/developingcountries

Fostering open access in Asia

Research output in Asia is growing fast. According to National Science Foundation indicators published in February this year, the number of articles published by researchers in Asian countries increased from 89,000 in 1997 to 212,000 in 2011.

If that trend continues, Asia – with China very much in the vanguard – is likely to overtake both the US and European Union in terms of research output in the very near future. A Royal Society report from 2011 predicted that China would overtake the US sometime around now!

http://blogs.biomedcentral.com/bmcblog/2014/03/28/fostering-open-access-in-asia/

Open Access Publisher

Bio Med Central The Open Access Publisher

BioMed Central is an STM (Science, Technology and Medicine) publisher of 270 peer-reviewed open access journals. The portfolio of journals spans all areas of biology, biomedicine and medicine and includes broad interest titles, such as BMC Biology and BMC Medicine alongside specialist journals, such as Retrovirology and BMC Genomics. All original research articles published by BioMed Central are made freely accessible online immediately upon publication. BioMed Central levies an article-processing charge to cover the cost of the publication process. Authors publishing with BioMed Central retain the copyright to their work, licensing it under the Creative Commons Attribution License which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited. BioMed Central is owned by Springer Science+Business Media, and also hosts the SpringerOpen platform.

The Journals can be Browsed by the subject:

http://www.biomedcentral.com/journals